567 related articles for article (PubMed ID: 27039905)
1. Association of serum chloride level with mortality and cardiovascular events in chronic kidney disease: the CKD-ROUTE study.
Mandai S; Kanda E; Iimori S; Naito S; Noda Y; Kikuchi H; Akazawa M; Oi K; Toda T; Sohara E; Okado T; Sasaki S; Rai T; Uchida S
Clin Exp Nephrol; 2017 Feb; 21(1):104-111. PubMed ID: 27039905
[TBL] [Abstract][Full Text] [Related]
2. Cardiac troponin T elevation at dialysis initiation is associated with all-cause and cardiovascular mortality on dialysis in patients without diabetic nephropathy.
Hayashi T; Kimura T; Yasuda K; Sasaki K; Obi Y; Rakugi H; Isaka Y
Clin Exp Nephrol; 2017 Apr; 21(2):333-341. PubMed ID: 27178276
[TBL] [Abstract][Full Text] [Related]
3. Anaemia management and mortality risk in newly visiting patients with chronic kidney disease in Japan: The CKD-ROUTE study.
Iimori S; Naito S; Noda Y; Nishida H; Kihira H; Yui N; Okado T; Sasaki S; Uchida S; Rai T
Nephrology (Carlton); 2015 Sep; 20(9):601-8. PubMed ID: 25917812
[TBL] [Abstract][Full Text] [Related]
4. Association of serum sodium levels with all-cause and cardiovascular mortality in chronic kidney disease: Results from a prospective observational study.
Chiu DY; Kalra PA; Sinha S; Green D
Nephrology (Carlton); 2016 Jun; 21(6):476-82. PubMed ID: 26426983
[TBL] [Abstract][Full Text] [Related]
5. Cause of Death in Patients With Diabetic CKD Enrolled in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).
Charytan DM; Lewis EF; Desai AS; Weinrauch LA; Ivanovich P; Toto RD; Claggett B; Liu J; Hartley LH; Finn P; Singh AK; Levey AS; Pfeffer MA; McMurray JJ; Solomon SD
Am J Kidney Dis; 2015 Sep; 66(3):429-40. PubMed ID: 25935581
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of hypochloremia versus hyponatremia among patients with chronic kidney disease-a retrospective cohort study.
Kubota K; Sakaguchi Y; Hamano T; Oka T; Yamaguchi S; Shimada K; Matsumoto A; Hashimoto N; Mori D; Matsui I; Isaka Y
Nephrol Dial Transplant; 2020 Jun; 35(6):987-994. PubMed ID: 30346587
[TBL] [Abstract][Full Text] [Related]
7. Soluble TWEAK and Major Adverse Cardiovascular Events in Patients with CKD.
Fernández-Laso V; Sastre C; Valdivielso JM; Betriu A; Fernández E; Egido J; Martín-Ventura JL; Blanco-Colio LM
Clin J Am Soc Nephrol; 2016 Mar; 11(3):413-22. PubMed ID: 26728587
[TBL] [Abstract][Full Text] [Related]
8. Low white blood cell count is independently associated with chronic kidney disease progression in the elderly: the CKD-ROUTE study.
Arai Y; Kanda E; Iimori S; Naito S; Noda Y; Sasaki S; Sohara E; Okado T; Rai T; Uchida S
Clin Exp Nephrol; 2018 Apr; 22(2):291-298. PubMed ID: 28699033
[TBL] [Abstract][Full Text] [Related]
9. Association of IL-6 and a functional polymorphism in the IL-6 gene with cardiovascular events in patients with CKD.
Spoto B; Mattace-Raso F; Sijbrands E; Leonardis D; Testa A; Pisano A; Pizzini P; Cutrupi S; Parlongo RM; D'Arrigo G; Tripepi G; Mallamaci F; Zoccali C
Clin J Am Soc Nephrol; 2015 Feb; 10(2):232-40. PubMed ID: 25492254
[TBL] [Abstract][Full Text] [Related]
10. Nonesterified fatty acids and cardiovascular mortality in elderly men with CKD.
Xiong Z; Xu H; Huang X; Ärnlöv J; Qureshi AR; Cederholm T; Sjögren P; Lindholm B; Risérus U; Carrero JJ
Clin J Am Soc Nephrol; 2015 Apr; 10(4):584-91. PubMed ID: 25637632
[TBL] [Abstract][Full Text] [Related]
11. Association between serum Na-Cl level and renal function decline in chronic kidney disease: results from the chronic kidney disease Japan cohort (CKD-JAC) study.
Maruta Y; Hasegawa T; Yamakoshi E; Nishiwaki H; Koiwa F; Imai E; Hishida A
Clin Exp Nephrol; 2019 Feb; 23(2):215-222. PubMed ID: 30168046
[TBL] [Abstract][Full Text] [Related]
12. Plasma ceruloplasmin, a regulator of nitric oxide activity, and incident cardiovascular risk in patients with CKD.
Kennedy DJ; Fan Y; Wu Y; Pepoy M; Hazen SL; Tang WH
Clin J Am Soc Nephrol; 2014 Mar; 9(3):462-7. PubMed ID: 24311705
[TBL] [Abstract][Full Text] [Related]
13. Ratio of blood urea nitrogen to serum creatinine at initiation of dialysis is associated with mortality: a multicenter prospective cohort study.
Inaguma D; Koide S; Ito E; Takahashi K; Hayashi H; Hasegawa M; Yuzawa Y;
Clin Exp Nephrol; 2018 Apr; 22(2):353-364. PubMed ID: 28766029
[TBL] [Abstract][Full Text] [Related]
14. Association between renal function and cardiovascular and all-cause mortality in the community-based elderly population: results from the Specific Health Check and Guidance Program in Japan.
Kon S; Konta T; Ichikawa K; Asahi K; Yamagata K; Fujimoto S; Tsuruya K; Narita I; Kasahara M; Shibagaki Y; Iseki K; Moriyama T; Kondo M; Watanabe T
Clin Exp Nephrol; 2018 Apr; 22(2):346-352. PubMed ID: 28744566
[TBL] [Abstract][Full Text] [Related]
15. Vascular calcification in patients with nondialysis CKD over 3 years.
Górriz JL; Molina P; Cerverón MJ; Vila R; Bover J; Nieto J; Barril G; Martínez-Castelao A; Fernández E; Escudero V; Piñera C; Adragao T; Navarro-Gonzalez JF; Molinero LM; Castro-Alonso C; Pallardó LM; Jamal SA
Clin J Am Soc Nephrol; 2015 Apr; 10(4):654-66. PubMed ID: 25770175
[TBL] [Abstract][Full Text] [Related]
16. Association Between Circulating Ketone Bodies and Worse Outcomes in Hemodialysis Patients.
Obokata M; Negishi K; Sunaga H; Ishida H; Ito K; Ogawa T; Iso T; Ando Y; Kurabayashi M
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 28974498
[TBL] [Abstract][Full Text] [Related]
17. Advanced chronic kidney disease populations have elevated trimethylamine N-oxide levels associated with increased cardiovascular events.
Kim RB; Morse BL; Djurdjev O; Tang M; Muirhead N; Barrett B; Holmes DT; Madore F; Clase CM; Rigatto C; Levin A;
Kidney Int; 2016 May; 89(5):1144-1152. PubMed ID: 27083288
[TBL] [Abstract][Full Text] [Related]
18. Associations of Left Ventricular Hypertrophy and Geometry with Adverse Outcomes in Patients with CKD and Hypertension.
Paoletti E; De Nicola L; Gabbai FB; Chiodini P; Ravera M; Pieracci L; Marre S; Cassottana P; Lucà S; Vettoretti S; Borrelli S; Conte G; Minutolo R
Clin J Am Soc Nephrol; 2016 Feb; 11(2):271-9. PubMed ID: 26668021
[TBL] [Abstract][Full Text] [Related]
19. Low serum bilirubin level predicts the development of chronic kidney disease in patients with type 2 diabetes mellitus.
Ahn KH; Kim SS; Kim WJ; Kim JH; Nam YJ; Park SB; Jeon YK; Kim BH; Kim IJ; Kim YK
Korean J Intern Med; 2017 Sep; 32(5):875-882. PubMed ID: 28560862
[TBL] [Abstract][Full Text] [Related]
20. Subclinical markers of cardiovascular disease predict adverse outcomes in chronic kidney disease patients with normal left ventricular ejection fraction.
Sulemane S; Panoulas VF; Bratsas A; Grapsa J; Brown EA; Nihoyannopoulos P
Int J Cardiovasc Imaging; 2017 May; 33(5):687-698. PubMed ID: 28120157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
